Literature DB >> 23541782

New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone.

Thuy D T Vu1, Xiao Fang Wang, Qingju Wang, Natalie E Cusano, Dinaz Irani, Barbara C Silva, Ali Ghasem-Zadeh, Julia Udesky, Megan E Romano, Roger Zebaze, George Jerums, Stephanie Boutroy, John P Bilezikian, Ego Seeman.   

Abstract

In primary hyperparathyroidism (PHPT), protracted elevation of serum parathyroid hormone (PTH) is held to be associated with cortical, but not trabecular, bone loss. However, an alternative explanation for the apparent preservation of trabecular bone is fragmentation of the cortex by intracortical remodeling. The cortical fragments resemble trabeculae and so may be erroneously included in the quantification of 'trabecular' bone density. To test this hypothesis, we compared bone microarchitecture in 43 patients with untreated PHPT (mean 62.9 years, range 31-84) with 47 healthy age-matched controls and 25 patients with surgically treated PHPT (63.6 years, 30-82). Images of the distal radius and tibia were acquired using high-resolution peripheral quantitative CT and analysed using StrAx1.0, a new software program that quantifies bone morphology in-vivo. Results were expressed as the mean number of standardized deviations (SD) from the age-specific mean (Z scores, mean±SEM). In subjects with PHPT, total tibial cortical area was reduced -0.26±0.08 SD; p=0.002). Cortical volumetric bone mineral density (vBMD) was reduced (-0.29±0.06 SD; p<0.001) due to higher cortical porosity (0.32±0.06 SD; p<0.001) and lower tissue mineralization density (-0.21±0.06 SD; p=0.002). Medullary area was increased (0.26±0.08 SD; p=0.002) and trabecular vBMD was reduced (-0.14±0.04 SD; p<0.001). In subjects who underwent successful parathyroidectomy, cortical area (-0.18±0.10 SD; NS) and medullary area (0.18±0.10 SD; NS) did not differ from controls. Cortical vBMD was reduced (-0.15±0.05 SD; p=0.003) due to high porosity (0.15±0.05 SD; p=0.006), values numerically lower than in untreated PHPT. Tissue mineralization density (-0.26±0.04 SD; p<0.001) and trabecular vBMD were reduced (-0.16±0.04 SD, p<0.001). The results were similar in the distal radius. In PHPT, chronically elevated endogenous PTH does not spare trabecular bone; it causes bone loss and microarchitectural deterioration in both cortical and trabecular compartments of bone.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23541782      PMCID: PMC4308951          DOI: 10.1016/j.bone.2013.03.009

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  18 in total

Review 1.  Bone strength in primary hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

Review 2.  Bone disease in primary hyperparathyroidism.

Authors:  M Parisien; S J Silverberg; E Shane; D W Dempster; J P Bilezikian
Journal:  Endocrinol Metab Clin North Am       Date:  1990-03       Impact factor: 4.741

3.  Effect of ethnicity and age or menopause on the structure and geometry of iliac bone.

Authors:  Z H Han; S Palnitkar; D S Rao; D Nelson; A M Parfitt
Journal:  J Bone Miner Res       Date:  1996-12       Impact factor: 6.741

4.  A new method of segmentation of compact-appearing, transitional and trabecular compartments and quantification of cortical porosity from high resolution peripheral quantitative computed tomographic images.

Authors:  R Zebaze; A Ghasem-Zadeh; A Mbala; E Seeman
Journal:  Bone       Date:  2013-01-17       Impact factor: 4.398

5.  Bone morphology in primary hyperparathyroidism--a qualitative and quantitative study of 391 cases.

Authors:  G Delling
Journal:  Appl Pathol       Date:  1987

6.  Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling.

Authors:  R Hattner; B N Epker; H M Frost
Journal:  Nature       Date:  1965-05-01       Impact factor: 49.962

7.  In vivo high resolution 3D-QCT of the human forearm.

Authors:  A Laib; H J Häuselmann; P Rüegsegger
Journal:  Technol Health Care       Date:  1998-12       Impact factor: 1.285

8.  Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women.

Authors:  M Parisien; F Cosman; R W Mellish; M Schnitzer; J Nieves; S J Silverberg; E Shane; D Kimmel; R R Recker; J P Bilezikian
Journal:  J Bone Miner Res       Date:  1995-09       Impact factor: 6.741

9.  Skeletal disease in primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; L de la Cruz; D W Dempster; F Feldman; D Seldin; T P Jacobs; E S Siris; M Cafferty; M V Parisien
Journal:  J Bone Miner Res       Date:  1989-06       Impact factor: 6.741

10.  Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidism.

Authors:  L van Doorn; P Lips; J C Netelenbos; W H Hackeng
Journal:  Bone Miner       Date:  1993-12
View more
  20 in total

Review 1.  Hyperparathyroidism and Bone Health.

Authors:  Francisco Bandeira; Sara Cassibba
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

2.  Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study.

Authors:  M Osima; T T Borgen; M Lukic; G Grimnes; R M Joakimsen; E F Eriksen; Å Bjørnerem
Journal:  Osteoporos Int       Date:  2017-11-14       Impact factor: 4.507

Review 3.  Primary Hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

4.  Impaired geometry, volumetric density, and microstructure of cortical and trabecular bone assessed by HR-pQCT in both sporadic and MEN1-related primary hyperparathyroidism.

Authors:  W Wang; M Nie; Y Jiang; M Li; X Meng; X Xing; O Wang; W Xia
Journal:  Osteoporos Int       Date:  2019-10-23       Impact factor: 4.507

5.  Cortical and trabecular bone in pediatric end-stage kidney disease.

Authors:  Catarina G Carvalho; Renata C Pereira; Barbara Gales; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Pediatr Nephrol       Date:  2014-09-04       Impact factor: 3.714

6.  Altered trabecular bone morphology in adolescent and young adult athletes with menstrual dysfunction.

Authors:  Deborah M Mitchell; Padrig Tuck; Kathryn E Ackerman; Natalia Cano Sokoloff; Ryan Woolley; Meghan Slattery; Hang Lee; Mary L Bouxsein; Madhusmita Misra
Journal:  Bone       Date:  2015-06-27       Impact factor: 4.398

7.  Skeletal Microstructure and Estimated Bone Strength Improve Following Parathyroidectomy in Primary Hyperparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; Barbara C Silva; Yu-Kwang Donovan Tay; John M Williams; Sanchita Agarwal; Beatriz Omeragic; X Edward Guo; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

8.  Volumetric Cortical Bone Porosity Assessment with MR Imaging: Validation and Clinical Feasibility.

Authors:  Chamith S Rajapakse; Mahdieh Bashoor-Zadeh; Cheng Li; Wenli Sun; Alexander C Wright; Felix W Wehrli
Journal:  Radiology       Date:  2015-08       Impact factor: 11.105

Review 9.  Bone disease in primary hyperparathyroidism.

Authors:  Francisco Bandeira; Natalie E Cusano; Barbara C Silva; Sara Cassibba; Clarissa Beatriz Almeida; Vanessa Caroline Costa Machado; John P Bilezikian
Journal:  Arq Bras Endocrinol Metabol       Date:  2014-07

10.  Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Shonni J Silverberg; Bart L Clarke; Munro Peacock; Francisco Bandeira; Stephanie Boutroy; Natalie E Cusano; David Dempster; E Michael Lewiecki; Jian-Min Liu; Salvatore Minisola; Lars Rejnmark; Barbara C Silva; Marcella D Walker; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.